All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Tyrosine-protein kinase transmembrane receptor ROR1, also called neurotrophic tyrosine kinase receptor-related 1 (NTRKR1), belongs to the receptor tyrosine kinase-like orphan receptor (ROR) subfamily. It is a type I membrane protein, which is regulating neurite growth in the central nervous system. ROR1 is playing a functional role in the activity of ovarian cancer cells, and associated with B-cell chronic lymphocytic leukaemia.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0922-ZP1098 | Anti-ROR1 (UC-961) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | UC-961 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1200 | Anti-ROR1 (V282) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Mouse | V282 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1201 | Anti-ROR1 (V420) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Mouse | V420 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1202 | Anti-ROR1 (A14) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Mouse | A14 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-1022-LX1425 | Anti-ROR1 (X10X603) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X603 | Rabbit | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1426 | Anti-ROR1 (X10X604) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X604 | Rabbit | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1427 | Anti-ROR1 (X10X605) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X605 | human | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1428 | Anti-ROR1 (X10X606) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X606 | human | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1429 | Anti-ROR1 (X10X607) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X607 | human | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1430 | Anti-ROR1 (X10X608) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X608 | human | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1431 | Anti-ROR1 (X10X609) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X609 | human | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1432 | Anti-ROR1 (X10X610) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X610 | human | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1433 | Anti-ROR1 (X10X611) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X611 | Humanized | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1439 | Anti-ROR1 (X10X617) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X617 | Humanized | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX1440 | Anti-ROR1 (X10X618) h(41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X618 | Humanized | scFv-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2079 | Anti-ROR1 (X10X603) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X603 | Rabbit | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2080 | Anti-ROR1 (X10X604) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X604 | Rabbit | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2085 | Anti-ROR1 (X10X609) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X609 | human | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2086 | Anti-ROR1 (X10X610) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X610 | human | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX2087 | Anti-ROR1 (X10X611) h(CD28-41BB-CD3ζ) CAR, piggyBac vector system | Human | X10X611 | Humanized | scFv-CD28-41BB-CD3ζ | piggyBac transposon | T cell | ||
XS-0823-LX87 | Anti-hROR1 (12) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 12 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION